Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction

NCT01197742 | Completed

• 1 other identifier: Sweetheart
• Study Type: observational
• Target: 2,772
• Locations: 1 country
• Sites: 2

Brief Summary

The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.

Conditions

Diabetes; STEMI; NSTEMI; Myocardial Infarction

Keywords

Diabetes; STEMI; NSTEMI; Myocardial infarction

Outcome Measures

Primary Outcomes (1)

• Documentation of the characteristics consecutive patients with acute STEMI or NSTEMI in daily hospital routine in Germany

  04/01/2007-09/30/2009

Secondary Outcomes (5)

• Documentation of the fraction of patients with (I) a previous know Diabetes Mellitus (DM) type I and II, (II) a newly diagnosed DM, (III) diagnosed with IFG or IGT for the first time

  04/01/2007-09/30/2009

• Documentation of acute invasive and adjuvant medicamentous therapy of STEMI and NSREMI in hospital daily routine in Germany

  04/01/2007-09/30/2009

• Documentation of diabetic therapy during the acute phase of a myocardial infarction

  04/01/2007-09/30/2009

• Documentation of the hospital mortality, the serious but non-fatal complications (stroke, re-myocardial infarction) and other bleeding complications

  04/01/2007-09/30/2009

• Verification of the implementation of a therapy according to the guidelines for STEMI / NSTEMI in daily hospital routine

  04/01/2007-09/30/2009

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

all consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction or acute (no older than 24 h) Non-ST-Elevation Myocardial infarction.

You may qualify if:

• consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction
• consecutive patients with acute (no older than 24 h) Non-ST-Elevation Myocardial infarction

You may not qualify if:

• missing informed consent

Sponsors & Collaborators

• Stiftung Institut fuer Herzinfarktforschung: lead
• Sanofi: collaborator

Study Sites (2)

Städ Krankenhaus münchen Schwabing

München, 80804, Germany

Location

Klinikum Nürnberg Süd /Cardiology

Nuremberg, 90471, Germany

Location

MeSH Terms

Conditions

Diabetes Mellitus; ST Elevation Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Myocardial Infarction

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Officials

• Anselm K Gitt, MD

  Stiftung Institut für Herzinfarktforschung

  STUDY CHAIR

• Jochen Senges, MD

  Stiftung Institut für Herzinfarktforschung

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 7, 2010
• First Posted: September 9, 2010
• Study Start: April 20, 2007
• Primary Completion: October 5, 2009
• Study Completion: October 5, 2009
• Last Updated: December 20, 2024

Record last verified: 2024-12

Locations

DE (2)